The resolute Onyx in TIA management (ROTIA)

CONCLUSION: ROTIA demonstrates the feasibility of using the Resolute Onyx drug-eluting stent for the management of TIAs due to refractory ICAD, with high technical success and low peri-procedural complications. Limitations include the retrospective and single-center nature of this study. Future prospective, multi-center, randomized trials with extended observation periods are needed.PMID:38651294 | DOI:10.1177/15910199241249211

Source: Interventional Neuroradiology - April 23, 2024 Category: Radiology Authors: Ameer E Hassan Ahmed M Shoman Samantha Miller Abdulrahman Ibrahim Hagrass Sohum Desai Hamzah Saei Wondwossen G Tekle Source Type: research